Cancer Research UK scientists at the University of Southampton found that a new molecule targets the master switch - HIF-1 - that cancer cells use to adapt to low oxygen levels, a common feature in the disease.
The researchers uncovered a way to stop cancer cells using this switch through an approach called 'synthetic biology'. By testing 3.2 million potential compounds, made by specially engineered bacteria, they were able to find a molecule that stopped HIF-1 from working.
This prevented the cancer cells from responding and surviving.
More top news
More than 100 Auschwitz survivors from at least 17 countries are expected to attend the main ceremony at the concentration camp.
The recovery is slowing continuing, but it is being driven by the service industry instead of manufacturing - keeping the wealth in London.
Will the 'potentially historic' snow storm hitting the US, find its way to the UK?